Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-09-24
1995-05-02
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 17, 514563, 530328, 530329, 530330, 530332, 562561, A61K 3702, A61K 3764, C07K 706
Patent
active
054119561
ABSTRACT:
A lipolytic enzyme inhibitor is disclosed which comprises as an active ingredient at least one of a basic protein, a basic polypeptide and salt thereof. The inhibitor is useful as a dieting agent for the prevention of obesity and lipemia and as an additive for food and feed.
REFERENCES:
patent: 3867365 (1975-02-01), Stahmann et al.
patent: 4287185 (1981-09-01), Toyoshima et al.
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4803224 (1989-02-01), Tenmyo et al.
patent: 4818763 (1989-04-01), Rusch et al.
patent: 4867974 (1989-09-01), Fujii et al.
patent: 5009907 (1991-04-01), Fujii et al.
Agric. Biol. Chem., vol. 41, No. 9, issued 1977, Shima et al, "Polylsine Produced by Streptomyces", pp. 1807-1809.
Chemical Abstracts vol. 112:68564y (1990).
Biochemistry Correlations, Devlin, ed. John Wiley & Sons. 1982. pp. 1162-1164.
S. Budavari et al.: "The Merck Index", edition No. 11, 1989, Merck & Co., Rahway, N.J., US--p. 746, 43f. No. 4643.
Biological Abstracts, vol. 80, No. 3, 1985, p. AB-721, resume No. 24791, Philadelphia, Pa., US; J. Harenberg et al.: "Inhibition of low molecular weight heparin by protamine chloride in vivo", & Throb. Res., 38(1): 11-20, 1985 --En entier.
S. Budavari et al.: "The Merck Index", edition No. 11, 1989, Merck & Co., Rahway, N.J., US--pp. 1263-1264, ref. No. 7961.
Chemical Abstracts, vol. 103, No. 7, 19 aout 1985, p. 243, resume No. 50279p, Columbus, Ohio, US; A. N. Klimov et al: "Inhibition of lipoprotein lipolysis by polyarginine and study of the mechanism of its interaction with lipoprotein lipase", & Biokhimiya (Moscow) 1985, 50(5), 804-13--En entier.
J. Agric Food Chem., vol. 37, No. 4, 1989, pp. 873-877, Washington, D.C., US; D, Bercovici et al.: "Poly-L-lysine and multioligo (L-methionyl) poly-L-lysine as nutritional sources of essential amino acids"--En entier.
French Search Document-Bureau D.A. Casalonga--Josse, 8, Avenue Percier 75008 Paris--No. 90 16069.
Journal of Lipid Research, vol. 25, 1984, pp. 1214-1221, Y. Gargouri, et al., "Studies on the Inhibition of Pancreatic and Microbial Lipases by Soybean Proteins".
J. Agric. Food Chem, vol. 26, No. 4, 1978, pp. 794-796, C. Hernandez-Lucas, et al., "Identification and Purification of a Purothionin Homologue from Rye (Secale Cereale L.)".
Agr. Biol. Chem., vol. 34, No. 7, pp. 1089-1094, 1970, T. Okada, et al., "A Lethal Toxic Substance for Brewing Yeast in Wheat and Barley".
Febs. Lett. 1975, 53 (1), 1-4 Isolation of C-I and C-II activated lipoprotein lipases and protamine.
Plant Science 1989, 59, 35-43 Phospholipase D of rice bran. II The effects of the enzyme inhibitors and . . .
Aust J Biol Sci 1983, 36, 41-48 Lipoprotein Lipase of Sheep and Rat Adipose Tissues.
Acta Cuient Venezolana 1979, 30, 152-161 The cafactor effects of serum lipoproteins on lipoprotein lipase activity and . . .
J Dairy Sci. 1976, 59 (7), 1203-1214 Milk Protein Lipases: A Review.
Biokhimiya 1985, 50(5), 804-813 Inhibition of lipoprotein lipolysis by polyarginine and study on the . . .
Kodama Toshiaki
Maeda Taturo
Miyazaki Toshiyuki
Motoi Hirofumi
Okuda Hiromichi
Nisshin Flour Milling Co. Ltd.
Russel Jeffrey E.
LandOfFree
Lipolytic enzyme inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipolytic enzyme inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipolytic enzyme inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137180